{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:07:35Z","timestamp":1793948855906,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002560","name":"Soonchunhyang University","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100002560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic kidney disease (CKD) has a significant impact on global health. Studies have shown that subclinical thyroid dysfunction may be related to CKD, but the association between subclinical thyroid dysfunction and CKD in the general population is unclear. We aimed to evaluate the risk of CKD according to thyroid function status in a large cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed data from a nationwide, population-based, cross-sectional survey (KNHANES VI). A total of 3,257 participants aged\u2009\u2265\u200919 years who underwent thyroid and kidney function assessments were included in this study. CKD was defined as an estimated glomerular filtration rate\u2009&lt;\u200960 mL\/min\/1.73 m<jats:sup>2<\/jats:sup> and\/or urine albumin-creatinine ratio\u2009\u2265\u200930\u00a0mg\/g. The risk of CKD according to thyroid function status was assessed using logistic regression, adjusted for potential confounders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 6.7% of the participants had CKD. There were no significant differences in thyroid-stimulating hormone and free thyroxine levels between the groups with and without CKD. The proportion of participants with CKD was significantly different among the thyroid function status groups (p\u2009=\u20090.012) and tended to increase significantly in the following order: subclinical hyperthyroidism (1.5%), euthyroidism (6.6%), and subclinical hypothyroidism (12.6%) (p for trend\u2009&lt;\u20090.001). Subclinical hypothyroidism was a significant risk factor for CKD, even after adjusting for sex, age, household income, education, smoking, alcohol consumption, walking activity, abdominal obesity, hypertension, low high-density lipoprotein cholesterol, elevated triglycerides, hyperglycemia, free thyroxine, and thyroid-peroxidase anibody (odds ratio 2.161, 95% confidence interval 1.032\u20134.527, p\u2009=\u20090.041).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Subclinical hypothyroidism is an independent predictor of CKD in the general population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03111-7","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:16:25Z","timestamp":1679865385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Subclinical thyroid dysfunction and chronic kidney disease: a nationwide population-based study"],"prefix":"10.1186","volume":"24","author":[{"given":"Hye Jeong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Won","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoil","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Hi","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"issue":"10225","key":"3111_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"regional Global","year":"2020","unstructured":"Global regional, national burden of chronic kidney disease. 1990\u20132017: a systematic analysis for the global burden of Disease Study 2017. Lancet (London England). 2020;395(10225):709\u201333.","journal-title":"Lancet (London England)"},{"issue":"1","key":"3111_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","volume":"41","author":"J Coresh","year":"2003","unstructured":"Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J kidney diseases: official J Natl Kidney Foundation. 2003;41(1):1\u201312.","journal-title":"Am J kidney diseases: official J Natl Kidney Foundation"},{"issue":"9818","key":"3111_CR3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet (London England). 2012;379(9818):815\u201322.","journal-title":"Lancet (London England)"},{"issue":"3","key":"3111_CR4","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1016\/S2214-109X(14)70002-6","volume":"2","author":"JW Stanifer","year":"2014","unstructured":"Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U. The epidemiology of chronic kidney disease in sub-saharan Africa: a systematic review and meta-analysis. The Lancet Global health. 2014;2(3):e174\u2013181.","journal-title":"The Lancet Global health"},{"issue":"7","key":"3111_CR5","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1681\/ASN.2015050542","volume":"27","author":"K Br\u00fcck","year":"2016","unstructured":"Br\u00fcck K, Stel VS, Gambaro G, Hallan S, V\u00f6lzke H, \u00c4rnl\u00f6v J, Kastarinen M, Guessous I, Vinhas J, Stengel B, et al. CKD prevalence varies across the European General Population. J Am Soc Nephrology: JASN. 2016;27(7):2135\u201347.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"4","key":"3111_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1530\/EJE-08-0837","volume":"160","author":"P Iglesias","year":"2009","unstructured":"Iglesias P, D\u00edez JJ. Thyroid dysfunction and kidney disease. Eur J Endocrinol. 2009;160(4):503\u201315.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"3111_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","volume":"14","author":"A Jabbar","year":"2017","unstructured":"Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat reviews Cardiol. 2017;14(1):39\u201355.","journal-title":"Nat reviews Cardiol"},{"issue":"2","key":"3111_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.maturitas.2013.03.009","volume":"75","author":"B Gopinath","year":"2013","unstructured":"Gopinath B, Harris DC, Wall JR, Kifley A, Mitchell P. Relationship between thyroid dysfunction and chronic kidney disease in community-dwelling older adults. Maturitas. 2013;75(2):159\u201364.","journal-title":"Maturitas"},{"issue":"3","key":"3111_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4158\/EP12282.OR","volume":"19","author":"Y Ye","year":"2013","unstructured":"Ye Y, Gai X, Xie H, Jiao L, Zhang S. Impact of thyroid function on serum cystatin C and estimated glomerular filtration rate: a cross-sectional study. Endocr practice: official J Am Coll Endocrinol Am Association Clin Endocrinologists. 2013;19(3):397\u2013403.","journal-title":"Endocr practice: official J Am Coll Endocrinol Am Association Clin Endocrinologists"},{"issue":"6","key":"3111_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1530\/EJE-16-0537","volume":"175","author":"L Chaker","year":"2016","unstructured":"Chaker L, Sedaghat S, Hoorn EJ, Elzen WP, Gussekloo J, Hofman A, Ikram MA, Franco OH, Dehghan A, Peeters RP. The association of thyroid function and the risk of kidney function decline: a population-based cohort study. Eur J Endocrinol. 2016;175(6):653\u201360.","journal-title":"Eur J Endocrinol"},{"key":"3111_CR11","doi-asserted-by":"crossref","unstructured":"Schultheiss UT, Daya N, Grams ME, Seufert J, Steffes M, Coresh J, Selvin E, K\u00f6ttgen A. Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 2017, 32(11):1874\u20131881.","DOI":"10.1093\/ndt\/gfw301"},{"issue":"1","key":"3111_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/EJE-10-0705","volume":"164","author":"BO Asvold","year":"2011","unstructured":"Asvold BO, Bj\u00f8ro T, Vatten LJ. Association of thyroid function with estimated glomerular filtration rate in a population-based study: the HUNT study. Eur J Endocrinol. 2011;164(1):101\u20135.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"3111_CR13","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/jgs.14102","volume":"64","author":"MH Chuang","year":"2016","unstructured":"Chuang MH, Liao KM, Hung YM, Wang PY, Chou YC, Chou P. Abnormal thyroid-stimulating hormone and chronic kidney Disease in Elderly adults in Taipei City. J Am Geriatr Soc. 2016;64(6):1267\u201373.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"3111_CR14","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s10157-017-1400-2","volume":"21","author":"\u00c9JF de Peixoto","year":"2017","unstructured":"de Peixoto \u00c9JF, Bittencourt MS, Goulart AC, Santos IS, de Oliveira Titan SM, Ladeira RM, Barreto SM, Lotufo PA, Bense\u00f1or IJM. Thyrotropin levels are associated with chronic kidney disease among healthy subjects in cross-sectional analysis of the brazilian longitudinal study of Adult Health (ELSA-Brasil). Clin Exp Nephrol. 2017;21(6):1035\u201343.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"3111_CR15","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/s41598-018-19693-4","volume":"8","author":"YC Chang","year":"2018","unstructured":"Chang YC, Chang CH, Yeh YC, Chuang LM, Tu YK. Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study. Sci Rep. 2018;8(1):2031.","journal-title":"Sci Rep"},{"issue":"1","key":"3111_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3803\/EnM.2017.32.1.106","volume":"32","author":"WG Kim","year":"2017","unstructured":"Kim WG, Kim WB, Woo G, Kim H, Cho Y, Kim TY, Kim SW, Shin MH, Park JW, Park HL, et al. Thyroid stimulating hormone reference range and prevalence of thyroid dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015. Endocrinol metabolism (Seoul Korea). 2017;32(1):106\u201314.","journal-title":"Endocrinol metabolism (Seoul Korea)"},{"issue":"6","key":"3111_CR17","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/cen.13606","volume":"88","author":"S Park","year":"2018","unstructured":"Park S, Kim WG, Jeon MJ, Kim M, Oh HS, Han M, Kim TY, Shong YK, Kim WB. Serum thyroid-stimulating hormone levels and smoking status: data from the Korean National Health and Nutrition Examination Survey VI. Clin Endocrinol. 2018;88(6):969\u201376.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"3111_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hep.24376","volume":"54","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, Ratziu V, McCullough A. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology (Baltimore MD). 2011;54(1):344\u201353.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"3","key":"3111_CR19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/hep.28376","volume":"63","author":"YH Lee","year":"2016","unstructured":"Lee YH, Kim SU, Song K, Park JY, Kim DY, Ahn SH, Lee BW, Kang ES, Cha BS, Han KH. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008\u20132011). Hepatology (Baltimore MD). 2016;63(3):776\u201386.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"5","key":"3111_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1530\/EJE-21-0634","volume":"185","author":"HJ Kim","year":"2021","unstructured":"Kim HJ, Park SJ, Park HK, Byun DW, Suh K, Yoo MH. Thyroid autoimmunity and metabolic syndrome: a nationwide population-based study. Eur J Endocrinol. 2021;185(5):707\u201315.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"3111_CR21","doi-asserted-by":"publisher","first-page":"e0270126","DOI":"10.1371\/journal.pone.0270126","volume":"17","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Park SJ, Park HK, Byun DW, Suh K, Yoo MH. Association of free thyroxine with obstructive lung pattern in euthyroid middle-aged subjects: a population-based study. PLoS ONE. 2022;17(7):e0270126.","journal-title":"PLoS ONE"},{"issue":"9403","key":"3111_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"Appropriate body-mass","year":"2004","unstructured":"Appropriate body-mass. Index for asian populations and its implications for policy and intervention strategies. Lancet (London England). 2004;363(9403):157\u201363.","journal-title":"Lancet (London England)"},{"issue":"9","key":"3111_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"11","key":"3111_CR24","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825\u201330.","journal-title":"Ann Intern Med"},{"issue":"9889","key":"3111_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","volume":"382","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet (London England). 2013;382(9889):339\u201352.","journal-title":"Lancet (London England)"},{"issue":"9","key":"3111_CR26","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1089\/thy.2017.0414","volume":"28","author":"S Moon","year":"2018","unstructured":"Moon S, Kim MJ, Yu JM, Yoo HJ, Park YJ. Subclinical hypothyroidism and the risk of Cardiovascular Disease and all-cause mortality: a Meta-analysis of prospective cohort studies. Thyroid: official journal of the American Thyroid Association. 2018;28(9):1101\u201310.","journal-title":"Thyroid: official journal of the American Thyroid Association"},{"issue":"1","key":"3111_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1681\/ASN.2010070766","volume":"23","author":"LH Mariani","year":"2012","unstructured":"Mariani LH, Berns JS. The renal manifestations of thyroid disease. J Am Soc Nephrology: JASN. 2012;23(1):22\u20136.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"6","key":"3111_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1089\/thy.2012.0475","volume":"23","author":"DH Shin","year":"2013","unstructured":"Shin DH, Lee MJ, Lee HS, Oh HJ, Ko KI, Kim CH, Doh FM, Koo HM, Kim HR, Han JH, et al. Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism. Thyroid: official journal of the American Thyroid Association. 2013;23(6):654\u201361.","journal-title":"Thyroid: official journal of the American Thyroid Association"},{"issue":"1","key":"3111_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/kisup.2011.6","volume":"1","author":"D Fliser","year":"2011","unstructured":"Fliser D, Wiecek A, Suleymanlar G, Ortiz A, Massy Z, Lindholm B, Martinez-Castelao A, Agarwal R, Jager KJ, Dekker FW, et al. The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda. Kidney Int supplements. 2011;1(1):6\u20139.","journal-title":"Kidney Int supplements"},{"issue":"8","key":"3111_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1089\/1050725041692891","volume":"14","author":"AS Cikim","year":"2004","unstructured":"Cikim AS, Oflaz H, Ozbey N, Cikim K, Umman S, Meric M, Sencer E, Molvalilar S. Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism. Thyroid: official journal of the American Thyroid Association. 2004;14(8):605\u20139.","journal-title":"Thyroid: official journal of the American Thyroid Association"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03111-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03111-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03111-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:17:48Z","timestamp":1679865468000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03111-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3111"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03111-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with the principles of the Declaration of Helsinki. Participation was voluntary, and written informed consent was obtained from all individuals. All survey protocols were approved by the Institutional Review Board of the KCDC (approval numbers: 2013-07CON-03-4\u00a0C and 2013-12EXP-03-5\u00a0C).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}